Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human pegivirus identified in severe myelitis and optic neuritis in immunocompromised patients: A pathogenic role for a forgotten virus?
Valyraki N, Maillart E, Pourcher V, Shor N, Tran S, Boudot de la Motte M, Houillier C, Domont F, Morvan E, Touat M, Del Mar Amador M, Aboab J, Mathon B, Hesters A, Vignal-Clermont C, Dehais C, Bonnin S, Lafitte F, Villain N, Varnous S, Gout O, Eloit M, Rodriguez C, Deschamps R. Valyraki N, et al. Among authors: gout o. Rev Neurol (Paris). 2023 Apr;179(4):361-367. doi: 10.1016/j.neurol.2022.06.011. Epub 2022 Oct 24. Rev Neurol (Paris). 2023. PMID: 36302709
[Acute disseminated encephalomyelitis].
Gout O. Gout O. Rev Neurol (Paris). 2002 Jan;158(1):114-22. Rev Neurol (Paris). 2002. PMID: 11938333 Review. French. No abstract available.
Blindness, weakness, and tingling.
Biotti D, Vignal C, Sharshar T, Gout O, McCoy AN, Miller NR. Biotti D, et al. Among authors: gout o. Surv Ophthalmol. 2012 Nov;57(6):565-72. doi: 10.1016/j.survophthal.2011.10.002. Epub 2012 Mar 6. Surv Ophthalmol. 2012. PMID: 22398335
Multiple sclerosis reactivations after fingolimod discontinuation for pregnancy planning.
Jeantin L, Bensa-Koscher C, Deschamps R, Gout O, Maillart E, Papeix C, Boudot de la Motte M. Jeantin L, et al. Among authors: gout o. J Neurol Neurosurg Psychiatry. 2024 Dec 4:jnnp-2024-334629. doi: 10.1136/jnnp-2024-334629. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39631786 No abstract available.
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
Jouvenot G, Courbon G, Lefort M, Rollot F, Casey R, Le Page E, Michel L, Edan G, de Seze J, Kremer L, Bigaut K, Vukusic S, Mathey G, Ciron J, Ruet A, Maillart E, Labauge P, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Stankoff B, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al-Khedr A, Casez O, Bourre B, Cabre P, Wahab A, Magy L, Camdessanché JP, Doghri I, Moulin S, Ben-Nasr H, Labeyrie C, Hankiewicz K, Neau JP, Pottier C, Nifle C, Collongues N, Kerbrat A; OFSEP Investigators. Jouvenot G, et al. JAMA Neurol. 2024 May 1;81(5):490-498. doi: 10.1001/jamaneurol.2024.0395. JAMA Neurol. 2024. PMID: 38526462
Natalizumab extended-interval dosing in a real-life setting.
Jeantin L, Boudot de la Motte M, Deschamps R, Gueguen A, Gout O, Lecler A, Papeix C, Bensa C. Jeantin L, et al. Among authors: gout o. J Neurol Sci. 2023 Jul 15;450:120689. doi: 10.1016/j.jns.2023.120689. Epub 2023 May 13. J Neurol Sci. 2023. PMID: 37210938
233 results